The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue
+0.56%
EPS
+357.1%
Free cash flow
+66.0%
Total debt
+2.66%

Quarter to July 2026, against a year earlier

62.29 1.22 −1.92%
Market cap
$12.1B
P/E
21.3×
Fwd P/E
17.5×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a

The Cooper Companies, Inc. (COO) Operating cash flow

Alert me on Operating cash flow

The Cooper Companies, Inc.'s operating cash flow for fiscal 2025 was $796.1M, up 12.2% from $709.3M in fiscal 2024. Over the twelve months to 31 July 2026 it was $1.0B. Over the past ten years it has ranged from $390.9M (fiscal 2015) to $796.1M (fiscal 2025) — the current reading is the highest in ten years. The Cooper Companies, Inc. ranks 7th of 51 Medical Instruments & Supplies companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $796.1M 12.24%
FY2024 $709.3M 16.76%
FY2023 $607.5M (12.26%)
FY2022 $692.4M (6.26%)
FY2021 $738.6M 51.79%
FY2020 $486.6M (31.77%)
FY2019 $713.2M 6.62%
FY2018 $668.9M 12.69%
FY2017 $593.6M 16.48%
FY2016 $509.6M 30.37%

Quarterly newest first

Period Operating cash flow Change
Jul 2026 $341.7M 86.93%
Apr 2026 $182.8M (29.93%)
Jan 2026 $260.9M 5.24%
Oct 2025 $247.9M (5.16%)
43 more quarters

Against its own ten years

Low $390.9M High $796.1M
Ten-year median $668.9M
Current reading's percentile 100

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on COO